openPR Logo
Press release

Global Cephalic Disorders Treatment Market Insights, Trends & Future Development Status Recorded during 2018-2028 / Key manufacturers Widex A/S, Oticon, Abbott Laboratories, GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Pfizer Inc., Takeda

01-09-2019 07:38 AM CET | Health & Medicine

Press release from: Fact.MR

Global Cephalic Disorders Treatment Market Insights, Trends &

The increasing screening and provisions for compulsory and free screening of newborns under the Children's Health Insurance Program (CHIP) and Medicaid is a prime driver of the Global Cephalic Disorders Treatment Market. The Patient Protection and Affordable Care Act (Affordable Care Act) requires most health plans to cover the federal Recommended Uniform Screening Panel (RUSP) of 31 core and 26 secondary newborn screening (NBS) tests with no coinsurance or copayments. This provision is expected to result in the coverage of almost 1.5 Million annual U.S. births, in addition to approximately 2 Million births covered under Medicaid. Newborn screening is also being provided by many third party payers and governments throughout the world are providing incentives for the same.

Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=1308

Cephalic disorders are congenital conditions characterized by damage or abnormal development of the nervous system. They are caused by multiple factors such as genetic, nutritional deficiencies and environmental exposure to infection or radiation during gestation. Cephalic disorders result in chronic, disabling disorders and even death. Common cephalic disorders include anencephaly, colpocephaly, holoprosencephaly, ethmocephaly, hydranencephaly, iniencephaly, lissencephaly, megalencephal, microcephaly, porencephaly, and schizencephaly. Anencephaly accounts for the largest share of cephalic disorders with almost 1,000 to 2,000 babies born with anencephaly each year in the U.S. The treatment for cephalic disorders includes drugs, surgery and occupational and behavioral therapy. However, there is a dearth of curative treatment and most patients receive symptomatic treatments based on conditions that vary by a large degree.

Tax incentives, grants for research and other provisions by governments for rare diseases are other factors driving the cephalic disorder treatment market growth. For example, under the Orphan Drug Act (ODA), economic incentives such as grants to academic-based researchers or companies are awarded for research. The government of UA also provides 50 % tax credit for expenditures incurred for clinical testing for orphan drugs. The Food and Drug Administration (FDA) also provides a 7-year market exclusivity for orphan diseases. ORPHANET, a consortium of 40 countries, is another initiative led by European countries. It lists isolated anencephaly, absence of innominate vein, holoprosencephaly and others cephalic disorders for grant benefits.

The development of healthcare infrastructure and per capita income is another trend driving the global cephalic disorders treatment market. Rising awareness and development in technologies such as genetic testing and surgery are driving faster market adoption for the global cephalic disorders treatment market. 

To know more about the Cephalic Disorders Treatment Market Visit the link- https://www.factmr.com/report/1308/cephalic-disorders-treatment-market

Poor efficacy and efficiency of treatment, risk of infection, poor success rates, high cost of treatment and absence of curative treatment for many cephalic disorders are expected to restraint the growth of the cephalic disorders treatment market.

The global market for cephalic disorders treatment is consolidated with a few large players dominating the scene. Most of the treatment is symptomatic and there is a dearth of curative treatment. Thus, any drug – even if partial curative – will be a block buster with rapid adoption and minimum marketing cost. A large opportunity exists in the hearing aids devices market and some of the established players in the global cephalic disorders treatment include Sonova Holding AG, Widex A/S, Oticon, Abbott Laboratories, GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Pfizer Inc., Takeda Pharmaceutical Company Ltd., and others.

Cephalic Disorders Treatment Market: Regional-Wise Outlook

The global cephalic disorders treatment market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan, Middle East and Africa. North America is expected to account for the largest share of the global cephalic disorders treatment market, owing to an excellent reimbursement rate, large healthcare expenditure amounting to 16 % of GDP in 2016 and compulsory screening under the affordable healthcare act. The provision of fast track approval by the FDA is expected to drive greater research in the area.

The Asia Pacific cephalic disorders treatment market is dominated by China and India and is expected to grow with the fastest CAGR, owing to the expansion of the healthcare industry and economic growth. Western Europe is expected to account for the second largest market, led by Germany, France and the U.K. The European cephalic disorders treatment market is expected to grow at a significant rate, owing to the incentives by European Council. The Middle East and Africa cephalic disorders treatment market is expected to be skewed in favor of the gulf economies of Saudi Arabia, Kuwait, and Qatar.

Cephalic Disorders Treatment Market: Key Players

Some of the major players operating in the global cephalic disorders treatment market include Sonova Holding AG, Widex A/S, Oticon, Abbott Laboratories, GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Pfizer Inc., Takeda Pharmaceutical Company Ltd. and others.

The global cephalic disorders treatment market is characterized by the absolute dearth of effective and curative treatment. Thus, research and development provides the largest market opportunity and any degree of success will lead to monopoly with an extremely large premium. Thus, partnership with large hospitals and organizations is an attractive strategy to eliminate the large development cost of drug research.

The global cephalic disorders treatment report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=1308

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cephalic Disorders Treatment Market Insights, Trends & Future Development Status Recorded during 2018-2028 / Key manufacturers Widex A/S, Oticon, Abbott Laboratories, GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Pfizer Inc., Takeda here

News-ID: 1481486 • Views:

More Releases from Fact.MR

Ice Skating Equipment Market worth is poised to reach US$ 1478 Billion in 2033
03-28-2024 | Sports
Fact.MR
Ice Skating Equipment Market worth is poised to reach US$ 1478 Billion in 2033
The global ice skating equipment market garnered a market value of US$ 6.87 Billion in 2022 and is expected to accumulate a market value of US$ 16.26 Billion by registering a CAGR of 9% in the forecast period 2023-2033. Ice skating is a popular activity observed in numerous snow-clad regions around the world, serving various purposes including exercise, leisure, and excitement. This recreational pursuit can occur in specially prepared ice arenas
Global Barcode Software Market is predicted to be valued at US$ 1.4 Billion by 2032
Global Barcode Software Market is predicted to be valued at US$ 1.4 Billion by 2 …
The barcode software market is predicted to grow at a moderate CAGR of 6.3% over the forecast period of 2022 to 2032. The barcode software market is estimated to achieve a net worth of about US$ 1.4 Billion in the year 2032, improving from US$ 694.9 Million recorded in 2021. For more insights into the Market, Get A Sample of this Report! https://www.factmr.com/connectus/sample?flag=S&rep_id=7368 The barcode software market emerges as a crucial enabler of
Hardware Acceleration is forecasted to accelerate at a commendable CAGR of 51% from 2023 to 2033
Hardware Acceleration is forecasted to accelerate at a commendable CAGR of 51% f …
The global hardware acceleration market stands at US$ 2.87 billion in 2023. Worldwide demand for hardware acceleration technology is projected to skyrocket at a CAGR of 51% and reach a market value of US$ 177 billion by 2033. Hardware acceleration refers to the use of specialized hardware components to perform specific tasks more efficiently than general-purpose processors. This technology has gained significant traction across various industries due to its ability to
03-28-2024 | Food & Beverage
Fact.MR
Marine Collagen Ingredients Market value is projected to reach US$ 2,320.6 milli …
According to Fact.MR analysis, the marine collagen ingredients market is poised for steady growth in the coming years. The market's overall value is anticipated to exceed US$ 2,320.6 million by the year 2033, a significant increase from US$ 1,076.8 million recorded in 2023. Projections indicate a robust compound annual growth rate (CAGR) of 8.0% during the assessment period spanning from 2023 to 2033. Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=8704 In recent

All 5 Releases


More Releases for Cephalic

Cephalic Protection Equipment Market 2020 Size, Status, Manufactures, Applicatio …
Latest released, the research study on Global Cephalic Protection Equipment Market Report Forecast 2021 - 2027, offers a detailed overview of the factors influencing the global business scope. Cephalic Protection Equipment Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Cephalic Protection Equipment.
Cephalic Protection Equipment Market Company Insights & SWOT Analysis by 2027 | …
This Cephalic Protection Equipment market report contains industry research, business goals, and recent trends, all of which are incredibly valuable to new market participants. This Cephalic Protection Equipment market report covers all of the important factors expected to drive market growth, such as growth drivers, restraints, and opportunities, threats, recent trends, and technological advances. By assessing the present market situation and future estimates, this market study studies the market in
08-01-2018 | Health & Medicine
Fact.MR
Cephalic Disorders Treatment Market 2018: Share, Trends, Analysis, Growth, Sales …
Cephalic disorders are congenital conditions characterized by damage or abnormal development of the nervous system. They are caused by multiple factors such as genetic, nutritional deficiencies and environmental exposure to infection or radiation during gestation. Cephalic disorders result in chronic, disabling disorders and even death. Common cephalic disorders include anencephaly, colpocephaly, holoprosencephaly, ethmocephaly, hydranencephaly, iniencephaly, lissencephaly, megalencephal, microcephaly, porencephaly, and schizencephaly. Anencephaly accounts for the largest share of cephalic disorders
Global Cephalic Protection Equipments Market Forecast 2018-2025 Bullard, 3M, Cin …
A detailed market study on "Global Cephalic Protection Equipments Market" examines the performance of the Cephalic Protection Equipments market. It encloses an in-depth Research of the Cephalic Protection Equipments market state and the competitive landscape globally. This report analyzes the potential of Cephalic Protection Equipments market in the present and the future prospects from various angles in detail. The Global Cephalic Protection Equipments Market 2018 report includes Cephalic Protection Equipments market
Global Cephalic Protection Equipments Market Drivers, Challenges, & Forecast 201 …
Qyresearchreports include new market research report "Global Cephalic Protection Equipments Market Research Report 2018" to its huge collection of research reports. A market intelligence report on the global market for Cephalic Protection Equipments has been added to enable key stakeholders in it to bet right on the market and thus improve their profit margins. The exhaustive report furnishes information on how the market for Cephalic Protection Equipments will evolve over the
Global Cephalic Protection Equipments Sales Market Overview, Trends and Growth O …
A fresh report has been added to the wide database of Market Research Hub (MRH). The research study is titled “Global Cephalic Protection Equipments Sales Market Report 2018” which encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview. The report anticipates that the market for Cephalic Protection Equipments would rise at a positive CAGR during the period